消費者醫療保健市場規模、佔有率、成長分析(按產品、分銷管道和地區)—2025-2032 年產業預測
市場調查報告書
商品編碼
1722353

消費者醫療保健市場規模、佔有率、成長分析(按產品、分銷管道和地區)—2025-2032 年產業預測

Consumer Healthcare Market Size, Share, and Growth Analysis, By Product (Dietary Supplements, OTC Pharmaceuticals), By Distribution Channel (Departmental Stores, Independent Retailers), By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到 2023 年,消費者保健市場規模將達到 2,923 億美元,從 2024 年的 3,139.3 億美元成長到 2032 年的 5,557.3 億美元,預測期內(2025-2032 年)的複合年成長率為 7.4%。

受老齡人口快速成長的推動,消費者保健市場將經歷顯著成長。根據世界衛生組織 (WHO) 報告,預計到 2050 年,中國 60 歲及以上成年人口將達到 21 億。在這一人群中,消化不良和慢性疼痛等與老齡化相關的疾病數量激增,導致對非處方藥 (OTC) 和膳食補充劑的需求增加。其消費者保健產品涉及健康促進、營養、口腔清潔用品和護膚等廣泛領域。該行業的擴張受到多種因素的推動,包括自我治療的上升、醫療保健成本的增加、對以患者為中心的護理的關注度的提高,以及從處方箋到非處方藥的轉變。此外,隨著可支配收入的增加,人們對健康和預防性醫療保健的接受度不斷提高,也進一步加強了消費者醫療保健領域。

目錄

介紹

  • 調查目的
  • 研究範圍
  • 定義

調查方法

  • 資訊採購
  • 二次資料和一次資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分機會分析

市場動態與展望

  • 市場概覽
  • 市場規模
  • 市場動態
    • 促進因素和機會
    • 限制與挑戰
  • 波特的分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數(2024年)
  • PESTEL分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 監管格局
  • 案例研究

消費者醫療保健市場規模(按產品和複合年成長率) (2025-2032)

  • 市場概覽
  • 營養補充品
  • 非處方藥

消費者保健市場規模(按分銷管道和複合年成長率) (2025-2032)

  • 市場概覽
  • 百貨公司
  • 獨立零售商
  • 藥房或藥局
  • 專業零售商
  • 超級市場或大賣場

各地區消費者醫療保健市場規模及複合年成長率(2025-2032)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業市場定位(2024年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2024年)
  • 主要企業簡介
    • 公司詳情
    • 產品系列分析
    • 公司分部佔有率分析
    • 收益與前一年同期比較對比(2022-2024 年)

主要企業簡介

  • Haleon plc(United Kingdom)
  • Kenvue Inc.(USA)
  • McKesson Corporation(USA)
  • Sun Pharmaceutical Industries Limited(India)
  • Zydus Wellness Limited(India)
  • Procter & Gamble Co.(USA)
  • Unilever plc(United Kingdom/Netherlands)
  • Nestle Health Science(Switzerland)
  • Reckitt Benckiser Group plc(United Kingdom)
  • Sanofi Consumer Healthcare(France)
  • Bayer Consumer Health(Germany)
  • Pfizer Consumer Healthcare(USA)
  • Johnson & Johnson Consumer Inc.(USA)
  • Abbott Laboratories(USA)
  • GlaxoSmithKline Consumer Healthcare(United Kingdom)
  • Amway Corporation(USA)
  • Herbalife Nutrition Ltd.(USA)
  • Nature's Bounty Co.(USA)

結論和建議

簡介目錄
Product Code: SQMIG35D2021

Consumer Healthcare Market size was valued at USD 292.3 billion in 2023 and is poised to grow from USD 313.93 billion in 2024 to USD 555.73 billion by 2032, growing at a CAGR of 7.4% during the forecast period (2025-2032).

The consumer healthcare market is set for substantial growth, driven by the rapidly increasing senior population, projected to reach 2.1 billion adults aged 60 and over by 2050, as reported by the World Health Organization. This demographic is experiencing a surge in age-related ailments, such as digestion issues and chronic pain, leading to higher demand for over-the-counter (OTC) medications and dietary supplements. Consumer healthcare products span health improvement, nutrition, oral, and skin care. The industry's expansion is fueled by rising self-medication trends, increasing healthcare costs, a greater focus on patient-centered care, and the shift from prescriptions to OTC options. Moreover, growing acceptance of wellness and preventive healthcare alongside higher disposable incomes further bolsters the consumer healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Consumer Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Consumer Healthcare Market Segments Analysis

Global Consumer Healthcare Market is segmented by Product, Distribution Channel and region. Based on Product, the market is segmented intoDietary Supplementsand OTC Pharmaceuticals. Based on Distribution Channel, the market is segmented into Departmental Stores, Independent Retailers, Pharmacies or Drugstores, Specialist Retailers and Supermarkets or Hypermarkets. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Consumer Healthcare Market

A significant driver of growth within the global consumer healthcare market is the positive shift in consumer attitudes toward health and wellness. As individuals become increasingly aware of the importance of preventive care and self-care, there is a notable trend toward seeking out non-prescription medications and nutritional products. This heightened awareness not only fuels market expansion but also contributes to a broader array of products becoming available to consumers. Consequently, as people prioritize their health and actively engage in self-care practices, the consumer healthcare market continues to flourish, reflecting the evolving needs and preferences of the population.

Restraints in the Consumer Healthcare Market

The progress of the global consumer healthcare market is significantly hindered by stringent regulations and compliance requirements. Manufacturers are compelled to adhere to comprehensive guidelines that govern product safety, efficacy, and marketing approaches. This necessity leads to elevated costs and prolonged timelines for launching new products, ultimately stifling innovation and leading to a stagnation in the development of essential offerings within the industry. As a result, the burdensome nature of these regulatory frameworks hampers the growth potential of the market, limiting the ability of companies to respond quickly to consumer needs and market trends.

Market Trends of the Consumer Healthcare Market

The consumer healthcare market is witnessing a robust trend toward personalization, driven by an increasing demand for tailored health solutions that cater to individual needs and preferences. This shift is fueled by advancements in data analytics and technology, enabling organizations to develop customized health regimens, targeted supplements, and personalized wellness services. By focusing on the unique health requirements of diverse consumers, companies not only enhance customer satisfaction and loyalty but also foster a deeper connection between brands and their clientele. As this trend continues to evolve, it is expected to shape the landscape of consumer healthcare, promoting innovation and improving overall health outcomes.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies

Global Consumer Healthcare Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Dietary Supplements
  • OTC Pharmaceuticals

Global Consumer Healthcare Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Departmental Stores
  • Independent Retailers
  • Pharmacies or Drugstores
  • Specialist Retailers
  • Supermarkets or Hypermarkets

Global Consumer Healthcare Market Size & CAGR (2025-2032)

  • North America (Product, Distribution Channel)
    • US
    • Canada
  • Europe (Product, Distribution Channel)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Distribution Channel)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Distribution Channel)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Distribution Channel)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Haleon plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kenvue Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • McKesson Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sun Pharmaceutical Industries Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zydus Wellness Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Procter & Gamble Co. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Unilever plc (United Kingdom/Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nestle Health Science (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Reckitt Benckiser Group plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi Consumer Healthcare (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer Consumer Health (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Consumer Healthcare (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson Consumer Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline Consumer Healthcare (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amway Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Herbalife Nutrition Ltd. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nature's Bounty Co. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations